PL2640734T3 - Aminoglikozydy i ich zastosowania w leczeniu zaburzeń genetycznych - Google Patents

Aminoglikozydy i ich zastosowania w leczeniu zaburzeń genetycznych

Info

Publication number
PL2640734T3
PL2640734T3 PL11799501T PL11799501T PL2640734T3 PL 2640734 T3 PL2640734 T3 PL 2640734T3 PL 11799501 T PL11799501 T PL 11799501T PL 11799501 T PL11799501 T PL 11799501T PL 2640734 T3 PL2640734 T3 PL 2640734T3
Authority
PL
Poland
Prior art keywords
aminoglycosides
genetic disorders
treating genetic
treating
disorders
Prior art date
Application number
PL11799501T
Other languages
English (en)
Polish (pl)
Inventor
Timor Baasov
Dana Atia-Glikin
Jeyakumar Kandasamy
Valery Belakhov
Original Assignee
Technion Research & Development Foundation Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Technion Research & Development Foundation Ltd. filed Critical Technion Research & Development Foundation Ltd.
Publication of PL2640734T3 publication Critical patent/PL2640734T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D79/00—Kinds or details of packages, not otherwise provided for
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
    • C07H15/222—Cyclohexane rings substituted by at least two nitrogen atoms
    • C07H15/226—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings
    • C07H15/228—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to adjacent ring-carbon atoms of the cyclohexane rings
    • C07H15/23—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to adjacent ring-carbon atoms of the cyclohexane rings with only two saccharide radicals in the molecule, e.g. ambutyrosin, butyrosin, xylostatin, ribostamycin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/04—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
    • C07H5/06—Aminosugars

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Mechanical Engineering (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL11799501T 2010-11-18 2011-11-17 Aminoglikozydy i ich zastosowania w leczeniu zaburzeń genetycznych PL2640734T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41495610P 2010-11-18 2010-11-18
PCT/IL2011/000889 WO2012066546A1 (en) 2010-11-18 2011-11-17 Aminoglycosides and uses thereof in treating genetic disorders
EP11799501.9A EP2640734B1 (en) 2010-11-18 2011-11-17 Aminoglycosides and uses thereof in treating genetic disorders

Publications (1)

Publication Number Publication Date
PL2640734T3 true PL2640734T3 (pl) 2018-04-30

Family

ID=45390144

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11799501T PL2640734T3 (pl) 2010-11-18 2011-11-17 Aminoglikozydy i ich zastosowania w leczeniu zaburzeń genetycznych

Country Status (18)

Country Link
US (7) US8895519B2 (el)
EP (2) EP3296311B1 (el)
JP (3) JP5960712B2 (el)
CA (1) CA2816789C (el)
CY (1) CY1120082T1 (el)
DK (1) DK2640734T3 (el)
ES (2) ES2833938T3 (el)
HK (1) HK1248709A1 (el)
HR (1) HRP20180056T1 (el)
HU (1) HUE036248T2 (el)
IL (3) IL266495B (el)
LT (1) LT2640734T (el)
NO (1) NO2640734T3 (el)
PL (1) PL2640734T3 (el)
PT (1) PT2640734T (el)
RS (1) RS56739B1 (el)
SI (1) SI2640734T1 (el)
WO (1) WO2012066546A1 (el)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3296311B1 (en) * 2010-11-18 2020-09-30 Technion Research & Development Foundation Ltd. Aminoglycosides and uses thereof in treating genetic disorders
KR101703137B1 (ko) 2014-05-30 2017-02-07 선문대학교 산학협력단 당 부가 아미노글리코사이드 화합물, 이의 제조방법 및 이를 유효성분으로 함유하는 약학적 조성물
US20170360817A1 (en) 2014-06-05 2017-12-21 Eloxx Pharmaceuticals Ltd. Use of aminoglycoside analogs in the treatment of rett syndrome
US10899785B2 (en) * 2015-09-02 2021-01-26 Eloxx Pharmaceuticals Ltd. Aminoglycoside derivatives and uses thereof in treating genetic disorders
WO2017037718A1 (en) * 2015-09-02 2017-03-09 Eloxx Pharmaceuticals Ltd. Aminoglycoside derivatives and uses thereof in treating genetic disorders
WO2017037717A1 (en) * 2015-09-02 2017-03-09 Eloxx Pharmaceuticals Ltd. Aminoglycoside derivatives and uses thereof in treating genetic disorders
US20190016746A1 (en) * 2016-01-05 2019-01-17 Eloxx Pharmaceuticals Ltd. Aminoglycoside derivatives and uses thereof in treating genetic disorders
US11136345B2 (en) * 2017-03-15 2021-10-05 Eloxx Pharmaceuticals Ltd. Large scale preparation of pseudo-trisaccharide aminoglycosides and of intermediates thereof
WO2019237076A1 (en) * 2018-06-07 2019-12-12 Eloxx Pharmaceuticals, Inc. Methods, compositions, and kits for inducing readthrough
KR102067477B1 (ko) * 2018-06-20 2020-01-17 고려대학교 산학협력단 스킬로이노사민을 포함하는 아미노사이클리톨 화합물, 이의 제조방법 및 이를 함유하는 약학 조성물
MX2021006146A (es) * 2018-11-29 2021-09-28 Eloxx Pharmaceuticals Metodos, composiciones y kits para tratar enfermedades oculares.
WO2021061873A1 (en) * 2019-09-23 2021-04-01 Eloxx Pharmaceuticals, Inc. Methods, compositions, and kits for treating polycystic kidney disease
EP4230196A1 (en) 2022-02-21 2023-08-23 Som Innovation Biotech, S.A. Compounds for use in the treatment of dystrophinopathies

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5960712A (ja) 1982-09-30 1984-04-06 Toshiba Corp デ−タ判別装置
JP5830213B2 (ja) 2004-02-17 2015-12-09 ザ ホスピタル フォー シック チルドレン Ｍｅｃｐ２ｅ１遺伝子
WO2007113841A2 (en) * 2006-04-03 2007-10-11 Technion Research & Development Foundation Ltd. Novel aminoglycosides and uses thereof in the treatment of genetic disorders
EP3296311B1 (en) 2010-11-18 2020-09-30 Technion Research & Development Foundation Ltd. Aminoglycosides and uses thereof in treating genetic disorders
US20170360817A1 (en) 2014-06-05 2017-12-21 Eloxx Pharmaceuticals Ltd. Use of aminoglycoside analogs in the treatment of rett syndrome

Also Published As

Publication number Publication date
US20200078386A1 (en) 2020-03-12
NO2640734T3 (el) 2018-03-17
US20140357590A1 (en) 2014-12-04
US20160074425A1 (en) 2016-03-17
US8895519B2 (en) 2014-11-25
JP6758338B2 (ja) 2020-09-23
EP2640734B1 (en) 2017-10-18
CA2816789A1 (en) 2012-05-24
SI2640734T1 (en) 2018-02-28
LT2640734T (lt) 2018-02-12
EP2640734A1 (en) 2013-09-25
US20210228608A1 (en) 2021-07-29
IL284067B (en) 2022-03-01
US9943533B2 (en) 2018-04-17
EP3296311B1 (en) 2020-09-30
JP2016121168A (ja) 2016-07-07
US9175029B2 (en) 2015-11-03
HK1248709A1 (zh) 2018-10-19
IL266495A (en) 2019-07-31
HRP20180056T1 (hr) 2018-02-09
ES2655916T3 (es) 2018-02-22
US20190224226A9 (en) 2019-07-25
PT2640734T (pt) 2018-01-22
IL266495B (en) 2020-09-30
IL277063B (en) 2021-07-29
JP2018123135A (ja) 2018-08-09
RS56739B1 (sr) 2018-03-30
CY1120082T1 (el) 2018-12-12
ES2833938T3 (es) 2021-06-16
HUE036248T2 (hu) 2018-06-28
DK2640734T3 (en) 2018-01-22
US20180200276A1 (en) 2018-07-19
WO2012066546A1 (en) 2012-05-24
EP3296311A1 (en) 2018-03-21
US10973839B2 (en) 2021-04-13
US20170182078A1 (en) 2017-06-29
JP2013542981A (ja) 2013-11-28
US10398718B2 (en) 2019-09-03
IL284067A (en) 2021-07-29
CA2816789C (en) 2018-12-11
JP5960712B2 (ja) 2016-08-02
US9616079B2 (en) 2017-04-11
US20130237489A1 (en) 2013-09-12
IL277063A (en) 2020-10-29
US11865128B2 (en) 2024-01-09

Similar Documents

Publication Publication Date Title
IL284067B (en) Derivatives of aminoglycosides, preparations containing them and their use for the treatment of genetic diseases
HK1201740A1 (en) Aptamers to -ngf and their use in treating -ngf mediated diseases and disorders -ngf -ngf
EP2496724A4 (en) Ni-Ti SEMICONDUCTOR AND CORRESPONDING METHODS
EP2632490A4 (en) NOVEL MOLECULES BINDING TO THE EGF RECEPTOR AND IMMUNOCONJUGATES THEREOF
PL2544682T3 (pl) Fitokannabinoidy w leczeniu glejaka
GB201010557D0 (en) RNA molecules and uses thereof
EP2558137A4 (en) METHODS AND COMBINATION
EP2707756A4 (en) REMOVAL OF REAL AMPLITUDE LAYERS IN FRACTURED MEDIA
HK1203952A1 (en) Substituted benzothienyl pyrrolotriazines and uses thereof in the treatment cancer
GB0912744D0 (en) Methods and uses
EP2734543A4 (en) LACTOFERRIN FRAGMENTS AND USE THEREOF
IL226108B (en) Mimochromes containing metals and their uses in chemistry and biology
EP2744786A4 (en) SUBSTITUTED 2-IMIDAZOLIDINONE AND 2-IMIDAZOLONE AND THEIR USE IN THE TREATMENT OF CANCER
GB201718726D0 (en) Phytocannabinoids in the treatment of cancer
EP2717900A4 (en) SCAFFOLD KINASE INTERACTION BLOCKADES AND ITS USE IN CANCER TREATMENT
GB0818663D0 (en) Gene regulation and its use in therapy
IL226390B (en) Derivatives of aminoglycosides, preparations containing them and their use for the treatment of genetic diseases
GB0900329D0 (en) Improvements in anti-ligature devices and methods
IL230474B (en) Lactoferrin segments and their uses
AU2012266896A1 (en) Scaffold-kinase interaction blockades and uses thereof in treating cancer
GB201004608D0 (en) Improvements in and to processes
GB201001384D0 (en) Light-fitting and associated methods
GB201018131D0 (en) 2 and 3 new poker
GB201117876D0 (en) Peptides and their use in treatment
GB201021105D0 (en) Improvements in and relating to parathas